We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Covered Stent Treats Acute Coronary Artery Perforation

By HospiMedica International staff writers
Posted on 20 Nov 2013
An innovative single layer covered stent system designed with high flexibility and deliverability can serve as a bailout stent for acute coronary artery perforations.

The PK Papyrus coronary stent is a sixth generation bare metal stent made of a cobalt-chromium alloy, which allows for thinner struts, while still maintaining optimal radial strength and radiopacity. More...
The thin struts, only 60 µm in diameter, also result in exceptional flexibility and deliverability of the stent, even in challenging vessels. The polyurethane membrane covering the stent is only 90 µm thin, thanks to an electrospinning process that results in 24% reduction in diameter over a sandwich design.

The diameter reduction means that the PK Papyrus fits in a 1.67 mm (5F) catheter, eliminating the need to switch access catheters during emergencies. In addition, the wide size range available—2.5–5.0 mm in diameter, 15–26 mm in length—enables a broad range of vessels to be treated confidently and efficiently. The PK Papyrus coronary stent is a product of BIOTRONIK (Buelach, Switzerland), and is based on the company’s Orsiro/PRO-Kinetic Energy stent platform. It has received the European community CE marking of approval.

“PK Papyrus is a testament to the engineering excellence at BIOTRONIK,” said Alexander Uhl, vice president of marketing at Vascular Intervention, BIOTRONIK. “The application of this electrospinning technology to the already highly deliverable BIOTRONIK Orsiro/PRO-Kinetic Energy stent platform has allowed us to introduce a novel product to the market that will enable physicians to treat patients in emergency situations quickly and safely.”

“In acute situations when there is a vessel perforation, I need a stent that is highly effective and has optimum deliverability,” said Prof. Georg Nickenig, MD, of University Hospital Bonn (Germany). “With PK Papyrus, I am confident that, if such a situation arises, I have a stent that is straight-forward to introduce into the artery with a flexibility that means simplified placement.”

Severe acute perforation is a rare but catastrophic event that has shown up to 20% mortality. One potential treatment is to exclude the defect by deploying a covered stent over the perforation, but many current covered stent designs necessitate large guide catheters, requiring physicians to switch guide catheters mid-way and delaying treatments.

Related Links:

BIOTRONIK



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.